22484271 18692765 18393603 19031025 26774254 31258326 25366120 29212933 18958172 21178490 35363588 18324887 33806942 30101349 23902512 23271969 25957966 35622847 25526819 28442605 26343011 19132113 24829464 25392212 24747773 18063023 19400762 2072986 - Search Results

Year	Number of Results
2007	2
2008	8
2009	8
2010	5
2011	8
2012	6
2013	3
2014	9
2015	17
2016	8
2017	8
2018	3
2019	5
2020	4
2021	3
2022	2

1

Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets.

Denizot M, Neal JW, Gasque P. Denizot M, et al. J Infect. 2012 Jul;65(1):1-16. doi: 10.1016/j.jinf.2012.03.019. Epub 2012 Apr 4. J Infect. 2012. PMID: 22484271 Review.

2

Ebola images emerge from the cave.

Diamond MS, Fremont DH. Diamond MS, et al. Cell Host Microbe. 2008 Aug 14;4(2):87-9. doi: 10.1016/j.chom.2008.07.011. Cell Host Microbe. 2008. PMID: 18692765 Free article.

3

Protection against filovirus infection: virus-like particle vaccines.

Yang C, Ye L, Compans RW. Yang C, et al. Expert Rev Vaccines. 2008 Apr;7(3):333-44. doi: 10.1586/14760584.7.3.333. Expert Rev Vaccines. 2008. PMID: 18393603 Review.

4

Role of epidermal dendritic cells in drug-induced cutaneous adverse reactions.

Ramírez-González MD, Herrera-Enríquez M, Villanueva-Rodríguez LG, Castell-Rodríguez AE. Ramírez-González MD, et al. Handb Exp Pharmacol. 2009;(188):137-62. doi: 10.1007/978-3-540-71029-5_7. Handb Exp Pharmacol. 2009. PMID: 19031025 Review.

5

[Ebola virus disease: Update].

de la Calle-Prieto F, Arsuaga-Vicente M, Mora-Rillo M, Arnalich-Fernandez F, Arribas JR. de la Calle-Prieto F, et al. Enferm Infecc Microbiol Clin. 2016 Aug-Sep;34(7):452-60. doi: 10.1016/j.eimc.2015.11.013. Epub 2016 Jan 13. Enferm Infecc Microbiol Clin. 2016. PMID: 26774254 Review. Spanish.

6

Filovirus Disease Outbreaks: A Chronological Overview.

Languon S, Quaye O. Languon S, et al. Virology (Auckl). 2019 Jun 21;10:1178122X19849927. doi: 10.1177/1178122X19849927. eCollection 2019. Virology (Auckl). 2019. PMID: 31258326 Free PMC article. Review.

7

Understanding organ dysfunction in Ebola virus disease.

Fletcher TE, Fowler RA, Beeching NJ. Fletcher TE, et al. Intensive Care Med. 2014 Dec;40(12):1936-9. doi: 10.1007/s00134-014-3515-1. Epub 2014 Nov 1. Intensive Care Med. 2014. PMID: 25366120 No abstract available.

8

Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.

Xiao JH, Rijal P, Schimanski L, Tharkeshwar AK, Wright E, Annaert W, Townsend A. Xiao JH, et al. J Virol. 2018 Jan 30;92(4):e00941-17. doi: 10.1128/JVI.00941-17. Print 2018 Feb 15. J Virol. 2018. PMID: 29212933 Free PMC article.

9

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.

Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. Croyle MA, et al. PLoS One. 2008;3(10):e3548. doi: 10.1371/journal.pone.0003548. Epub 2008 Oct 29. PLoS One. 2008. PMID: 18958172 Free PMC article.

10

Ebolavirus VP35 is a multifunctional virulence factor.

Leung DW, Prins KC, Basler CF, Amarasinghe GK. Leung DW, et al. Virulence. 2010 Nov-Dec;1(6):526-31. doi: 10.4161/viru.1.6.12984. Epub 2010 Nov 1. Virulence. 2010. PMID: 21178490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results